CLGNConference•prnewswire•
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
Sentiment:Negative (35)
Summary
REHOVOT, Israel, Aug. 25, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced that senior...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 25, 2025 by prnewswire